AA

Athiya Agarwal

Active Director Whole-Time Director DIN 01365659
DIN 01365659 First appointment Jul 1977 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 4 historical roles
Total affiliations 6 Since Jul 1977
Shareholding value •••• Premium profile

About Athiya Agarwal

Data last updated:

Athiya Agarwal is a Whole-Time Director at Dr. Agarwal's Eye Hospital Limited (since 1994) and Director at Dr Agarwal's Eye Institute Private Limited (since 1977). The companies operate in Healthcare and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹402 Cr; the largest is Dr. Agarwal's Eye Hospital Limited at ₹402 Cr (FY 2025). Earlier, Athiya Agarwal was a Director at Dr. Agarwal's Health Care Limited (2010) and Director at Senses Pharmaceuticals Private Limited (2008–2018) and 2 more.

DIN 01365659
Primary Designation Whole-Time Director
Industry Healthcare
First Appointment 20 Jul 1977
Oldest Company Age 49 yrs
Largest company Dr. Agarwal's Eye Hospital Limited · ₹402 Cr (FY 2025)
Combined revenue ₹402 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dr. Agarwal's Eye Hospital Limited L85110TN1994PLC027366
Whole-Time Director09 May 19941994₹402 Cr (FY 2025)Active
Director20 Jul 19771977₹11,270 (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dr. Agarwal's Health Care Limited L85100TN2010PLC075403
Director19 Apr 20102010₹2,125 Cr (FY 2026)Active
Director26 Nov 20082008₹26.08 Cr (FY 2025)Active
Dr.Agarwal's Pharma Limited U24231TN1997PLC038161
Director30 Sep 20051997Strike Off
Dr Agarwal's Opticals Limited U25205TN2008PLC069737
Director03 Nov 20082008Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dr. Agarwal's Eye Hospital Limited
Dr.Agarwal's Pharma Limited
Dr Agarwal's Opticals Limited
Dr Agarwal's Eye Institute Private Limited
Premium access

Shareholding and investment profile for Athiya Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Athiya Agarwal

Athiya Agarwal currently holds 2 directorships: Dr. Agarwal's Eye Hospital Limited (Whole-Time Director, since 09 May 1994, revenue ₹402 Cr (FY 2025)); Dr Agarwal's Eye Institute Private Limited (Director, since 20 Jul 1977, revenue ₹11,270 (FY 2024)).

Athiya Agarwal was first appointed on 20 Jul 1977 as Director at Dr Agarwal's Eye Institute Private Limited. The most recent appointment on record is 19 Apr 2010 at Dr. Agarwal's Health Care Limited.

The 2 current companies of Athiya Agarwal that report revenue have a combined latest revenue of ₹402 Cr: Dr. Agarwal's Eye Hospital Limited ₹402 Cr (FY 2025); Dr Agarwal's Eye Institute Private Limited ₹11,270 (FY 2024).

Athiya Agarwal held 4 earlier board appointments: Dr. Agarwal's Health Care Limited (Director, 19 Apr 2010 to 16 Aug 2010); Senses Pharmaceuticals Private Limited (Director, 26 Nov 2008 to 04 Apr 2018); Dr.Agarwal's Pharma Limited (Director, from 30 Sep 2005); Dr Agarwal's Opticals Limited (Director, from 03 Nov 2008).

The current boards of Athiya Agarwal's companies include Adil Agarwal (Dr. Agarwal's Eye Hospital Limited), Amar Agarwal (Dr. Agarwal's Eye Hospital Limited), Balakrishnan Venkatraman (Dr. Agarwal's Eye Hospital Limited), J Meenakshi (Dr. Agarwal's Eye Hospital Limited), Jagannathan Yaswanth Venkat (Dr. Agarwal's Eye Hospital Limited), Latha Ramanathan (Dr. Agarwal's Eye Hospital Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available